Magnetic resonance imaging for IMRT

Image-Guided IMRT

Volumn , Issue , 2006, Pages 177-186

  Verhey, Lynn J ^a   Chuang, Cynthia ^a   Pirzkall, Andrea ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746814408     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-30356-1_14     Document Type: Chapter

References (42)

1. Van de Wiele C (2005) PET and SPECT in IMRT: Future prospects. In: Bortfeld T, Schmidt-Ullrich R, De Neve W, editors. IMRT Handbook: Concepts & Clinical Applications. Springer, Berlin Heidelberg New York (this volume)
2. Khoo VS, Dearnaley DP, Finnigan DJ et al. (1997) Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol 42:1-15
3. Hill D, Hawkes D, Gleeson M et al. (1994) Accurate frameless registration of MR and CT images of the head: applications in planning surgery and radiation therapy. Radiology 191:447-454
4. Barillot C, Lemoine D, Le Briquer L et al. (1993) Data fusion in medical imaging: merging multimodal and multipatient images, identification of structures and 3D display aspects. Eur J Radiology 17:22-27
5. Treves S, Mitchell K, Habboush I (1998) Three dimensional image alignment, registration and fusion. J Nucl Med 42:83-92
6. Graves EE, Pirzkall A, Nelson SJ et al. (2001) Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning. Med Phys 28:2489-2496
7. Xia P, Pickett B, Vigneault E et al. (2001) Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treatmultiple dominant intraprostatic lesions of prostate cancer to 90 Gy. Int JRadiatOncol Biol Phys 51:244-254
8. Van den Berge DL, De Ridder MD, Storme GA (2000) Imaging in radiotherapy. Eur J Radiology 34:41-48
9. ChungN-N, TingL-L, HsuW-C et al. (2004) Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: Primary tumor target delineation for radiotherapy. HeadNeck 26:241-246
10. d'Arcy JA, Collins DJ, Rowland IJ et al. (2002) Applications of sliding window reconstruction with cartesian sampling for dynamic contrast enhanced MRI. NMR Biomed 15: 174-183
11. Shah GV, Fischbein NJ, Gandhi D et al. (2004) Dynamic contrast-enhanced MR imaging. Top Magn Reson Imaging 15:71-77
12. Yabuuchi H, Fukuya T, Tajima T et al. (2003) Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology 226:345-354
13. Schaefer JF, Vollmar J, Schick F et al. (2004) Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging-perfusion differences in malignant and benign lesions. Radiology 232:544-553
14. Liu P-F, Debatin J, Caduff R et al. (1998) Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol 71:501-509
15. Brix G, Kiessling F, Lucht R et al. (2004) Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 52:420-429
16. Kriege M, Brekelmans CTM, Boetes C et al. (2004) Efficacy of MRIandmammography forbreast-cancer screening inwomen with a familial or geneticpredisposition.NEngl JMed 351:427-437
17. Heinisch M, Gallowitsch HJ, Mikosch P et al. (2003) Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions. Breast 12:17-22
18. Huang W, Fisher PR, Dulaimy K et al. (2004) Detectionof breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232:585-591
19. EssermanL,WolvertonD,HyltonN(2002)Magnetic resonance imaging for primary breast cancer management: current role and new applications. Endocr Relat Cancer 9:141-153
20. Fischbein N, Noworolski S, Henry R et al. (2003) Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. Am J Neuroradiol 24:301-311
21. Barentsz JO, Engelbrecht M, Jager GJ et al. (1999) Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 10:295-304
22. Asaumi J-I, Yanagi Y, Hisatomi M et al. (2003) The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck. Eur J Radiol 48: 183-187
23. Ohno Y, Hatabu H, Takenaka D et al. (2004) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 231:872-879
24. Plathow C, Ley S, Fink C et al. (2004) Analysis of intrathoracic tumormobility duringwhole breathing cycle by dynamic MRI. Int J Radiat Oncol Biol Phys 59:952-959
25. Nelson SJ (2001) Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 46:228-239
26. Nelson SJ, McKnight TR, Henry RG (2002) Characterization of untreated gliomas by magnetic resonance spectroscopic imaging. Neuroimaging Clin N Am 12:599-613
27. Kurhanewicz J, Swanson MG,Nelson SJ et al. (2002) Combined magnetic resonance imaging and spectroscopic imaging approach tomolecular imaging of prostate cancer. J Magn Reson Imaging 16:451-463
28. Velema JP, Percy CL (1987) Age curves of central nervous systemtumor incidence in adults: variation of shape by histologic type. J Natl Cancer Inst 79:623-629
29. Laramore GE, Martz KL, Nelson JS et al. (1989) Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival? Int J Radiat Oncol Biol Phys 17:1357-1358
30. Hochberg FH,PruittA(1980)Assumptions inthe radiotherapy of glioblastoma. Neurology 30:907-911
31. Nakagawa K, Aoki Y et al. (1998) High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:1141-1149
32. Pirzkall A, McKnight T, Graves E et al. (2001)MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915-928
33. Pirzkall A, Li X, Oh J et al. (2004) 3D MRSI for resected highgrade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 59:126-137
34. Li X, Lu Y, Pirzkall Aet al. (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229-237
35. Yu KK, Hricak H (2000) Imaging prostate cancer. Radiol Clin North Am 38:59-85
36. Kurhanewicz J, Vigneron DB, Hricak H et al. (1996) Threedimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7) spatial resolution. Radiology 198:795-805
37. Kvistad KA, Bakken IJ, Gribbestad IS et al. (1999) Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy. J Magn Reson Imaging 10:159-164
38. Yeung DK, Yang W-T, Tse GM (2002) Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 225:190-197
39. Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. Radiology 220:40-46
40. Pui M, Wang Q, Xu B et al. (2004) MRI of gynecological neoplasm. J Clin Imaging 28:143-152
41. Graves E, Pirzkall A, Nelson S et al. (2001) Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning. Med Phys 28:2489-2496
42. Nelson SJ, Graves E, Pirzkall A et al. (2002) In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 16:464-476